RIL
APLT

Rothschild Investment LLC’s Applied Therapeutics APLT Stock Holding History

Rothschild Investment LLC’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35
Closed -$17 – 3027
2025
Q1 		$17 Sell
35
-40
-53% -$24 ﹤0.01% 3010
2024
Q4 		$64 Sell
75
-55
-42% -$345 ﹤0.01% 2923
2024
Q3 		$1.1K Buy
+130
New +$766 ﹤0.01% 2104

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Rothschild Investment LLC's APLT Position: Q2 2025 in Review

Rothschild Investment LLC sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 35 shares — an estimated $17 sold.

Rothschild Investment LLC first reported a position in APLT in Q3 2024 and held it in 3 quarters. The position peaked at $1.1K in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Rothschild Investment LLC reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 35 Applied Therapeutics shares in Q2 2025, an estimated $17.
  • Rothschild Investment LLC first reported a position in Applied Therapeutics in Q3 2024 and held it in 3 quarters.
  • Rothschild Investment LLC's Applied Therapeutics position peaked at $1.1K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Rothschild Investment LLC's 13F filing for Q2 2025, filed 11 Aug 2025.